R2platform datascience annals

 When you are performing a differential expression analysis or any other search that can yield many potentially intersting genes, then one often performs a gene ontology search or a gene set enrichment analysis, to identify processes that may be at the root of the result set that was identified. At some point, you may also become interested in a single gene and want to know more about this. This is where the pubsniffer tool, that is embedded in the R2 plaftorm comes in handy.  Pubsniffer is an automated analysis that can identify how many papers are found around a particular gene. It also allows you to immediately launch a pubreminer session that will try to present you with a term frequency analysis, to quickly condense a vast amount of scientific literature into a clickable overview. When used with 2 genes, then pubsniffer will also report sentences from abstracts, where both genes are being mentioned, in an attempt to proide you with concise information to help you identify the cont

Also 2023, has been quite a successful year for the R2 platform up to now. Citations keep coming in, which are a clear sign to us, that we are still filling a space in the scientific domain, by allowing every researcher to do datamining and datascience analyses and visualizations, without the need for bioinformatics or coding ecpertise.   If there are analyses, ideas or other suggestions on how we could improve the R2 platform, then do not hesitate to let us know via the support address on the R2 website (https://r2.amc.nl) Some recent ctations included in the graph above: 2451 Julson JR  et.al.  (2023). CDK4/6 Inhibition With Lerociclib is a Potential Therapeutic Strategy for the Treatment of Pediatric Sarcomas.  J Pediatr Surg   :. 2450 Chen PD  et.al.  (2023). Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway.  Oncogenesis   12 :49. 2449 Ali W  et.al.  (2023). Survival and Enrichment Analysis of Epithelial-Mesenchymal Tr